NCT00716638

Brief Summary

This study will evaluate the effectiveness of trauma-focused cognitive behaviour therapy (TF-CBT) versus eye movement desensitization and reprocessing (EMDR) in the treatment of trauma survivors with post-traumatic stress disorder (PTSD). Patients will be randomly assigned to TF-CBT or EMDR. Follow-up assessments will be conducted at 3 and 12 months post-treatment. In addition to comparing the efficacy of the two protocols, an additional focus will lie on identifying predictors for treatment outcome.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2008

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2008

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

July 14, 2008

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 16, 2008

Completed
7.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2015

Completed
Last Updated

September 13, 2018

Status Verified

September 1, 2018

Enrollment Period

7.3 years

First QC Date

July 14, 2008

Last Update Submit

September 11, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • PTSD symptom severity: (a) interviewer rating (PSS-I); (b) self-report (PDS)

    Assessed at post-treatment, 3 months and 12 months follow-up

Secondary Outcomes (3)

  • Depressive symptom severity (Beck Depression Inventory, BDI)

    assessed at post-treatment, 3 months and 12 months follow-up

  • Severity of anxiety symptoms (Beck Anxiety Inventory, BAI)

    assessed at posttreatment, 3 months and 12 months follow-up

  • Trauma-related appraisal (Posttraumatic Cognitions Inventory, PTCI)

    post-treatment

Study Arms (2)

Treatment group 1

EXPERIMENTAL

Trauma-focused Cognitive Behavior Therapy (TF-CBT)

Behavioral: Trauma-focused Cognitive Behavior Therapy

Treatment group 2

EXPERIMENTAL

Eye Movement Desensitization and Reprocessing (EMDR)

Behavioral: Eye Movement Desensitization and Reprocessing (EMDR)

Interventions

This intervention comprises 10 sessions of trauma-focused cognitive behavior therapy for PTSD with the components (a) prolonged imaginal exposure, (b) in vivo exposure, and (c) cognitive restructuring.

Treatment group 1

This intervention comprises 10 sessions of EMDR according to the standard protocol.

Treatment group 2

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A full diagnosis of PTSD according to the DSM-IV or subthreshold PTSD (criteria for intrusive re-experiencing are fulfilled and either three avoidance/numbing symptoms or two hyperarousal symptoms are present)
  • PTSD is related to one or more single-event traumas and participants have a clear memory of this event/these events (sufficient for constructing scenes to be used in exposure)
  • Age between 18 and 70
  • Sufficient fluency in Dutch to complete treatment and research protocol
  • If participants are using anti-depressants, they need to be on a stable dose for at least 2 weeks before the beginning of treatment and remain on this dose throughout the treatment.

You may not qualify if:

  • Dementia or other severe cognitive impairment
  • Psychosis
  • Depression with suicidal ideation
  • Bipolar disorder
  • Borderline Personality Disorder
  • Anti-social personality disorder
  • Substance dependence
  • Current use of tranquilizers
  • Exposure to prolonged and/or chronic trauma ("type-II-trauma")

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

PsyQ

Zaandam, 1500 AE, Netherlands

Location

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Interventions

Eye Movement Desensitization Reprocessing

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Desensitization, PsychologicBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Paul MG Emmelkamp, Professor

    University of Amsterdam

    PRINCIPAL INVESTIGATOR
  • Thomas Ehring, PhD

    University of Amsterdam

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 14, 2008

First Posted

July 16, 2008

Study Start

July 1, 2008

Primary Completion

November 1, 2015

Study Completion

November 1, 2015

Last Updated

September 13, 2018

Record last verified: 2018-09

Locations